4.4 Review

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels

Christian Fischer et al.

Article Biochemistry & Molecular Biology

Autocrine VEGF signaling is required for vascular homeostasis

Sunyoung Lee et al.

Article Biochemistry & Molecular Biology

Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2

Bradley K. McColl et al.

FASEB JOURNAL (2007)

Article Pathology

Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis

Lucie Kopfstein et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)

Article Hematology

Chimeric VEGF-ENZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization

Yujuan Zheng et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Hematology

Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes

Natsuo Inoue et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Multidisciplinary Sciences

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

Irene Noguera-Troise et al.

NATURE (2006)

Article Medicine, General & Internal

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Alan Sandler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow

CH Cho et al.

CIRCULATION RESEARCH (2005)

Article Biochemistry & Molecular Biology

VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

T Matsumoto et al.

EMBO JOURNAL (2005)

Article Multidisciplinary Sciences

Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice

Y Sakurai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

Circulating angiogenic factors and the risk of preeclampsia

RJ Levine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Multidisciplinary Sciences

Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development

NW Gale et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Biochemistry & Molecular Biology

Bone morphogenetic protein 4 mediates apoptosis of capillary endothelial cells during rat pupillary membrane regression

M Kiyono et al.

MOLECULAR AND CELLULAR BIOLOGY (2003)

Article Endocrinology & Metabolism

Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia

K Koga et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)

Article Biochemistry & Molecular Biology

VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice

A Kiba et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Biochemistry & Molecular Biology

Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians

S Yamaguchi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)